Browse studies
Find your next paid study
16 recruiting studies matching your filters
Phase 1
A Phase I/IIa, Single Site, Open-Label, Ascending Dose Study to Evaluate the Safety and Efficacy of OPF-310 [Encapsulated Porcine Islet Cells for Xenotransplantation] in Subjects With Type 1 Diabetes Mellitus
This study is First In Human study for Encapsulated Porcine Islet Cells for Xenotransplantation (OPF-310). The purpose of this study to assess the safety, tole…
Diabetes Mellitus, Type 1HypoglycemiaIslet Cell Transplantation+14 more
Estimated
~$10 – $8,750
Otsuka Pharmaceutical Factory, Inc.NCT06575426
Phase 1
A Phase I/II, Open-label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Anti-GPRC5D CAR-T Cell Product (OriCAR-017) in Subjects With Relapsed/Refractory Multiple Myeloma.
The is a first clinical study for Oricell Therapeutics Inc. in the United States to evaluate the safety, PK, PD and preliminary efficacy of our anti-GPRC5D cel…
Neoplasms, Plasma CellNeoplasms by Histologic TypeNeoplasms+11 more
Estimated
~$10 – $8,750
OriCell Therapeutics Co., Ltd.NCT06271252
Observational
Tracing Of Real-time glu13Cose Metabolism in Human Immune Cells
The purpose of this study is to understand how cells of the immune system use the common sugar glucose to fuel energy production and as a building block within…
GlucoseMetabolismIsotope Labeling+1 more
Estimated
~$10 – $6,250
Vanderbilt University Medical CenterNCT06930976
Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity
Background: Immune system and nervous system have significant interaction so that People with immunity diseases can have complications that affect the nervous…
Nervous System DiseaseImmune System Disease
Estimated
~$10 – $675
National Institute of Allergy and Infectious Diseases (NIAID)NCT06169150